Insights

Diverse Genomics Targeting 54gene focuses on expanding genomic diversity representation, presenting an opportunity to partner on multi-population sequencing projects, population-specific reference data, and inclusive clinical trial datasets to enhance product pipelines and regulatory support.

Strategic Leadership Shifts Recent CEO changes and leadership movements suggest an openness to strategic pivots and partnerships; engage to understand new strategic priorities, potential collaborations, and how Texas-size funding or exits could affect risk-sharing opportunities.

Funding & Growth Potential With substantial funding rounds totaling nearly $96M historically and a notable Series B, there may be appetite for co-developments, research collaborations, and grant-aligned initiatives that align with investor expectations and accelerated R&D timelines.

Cost-Optimization Precedents Past headcount reductions indicate sensitivity to cost structure; position offerings as efficiency-enhancing services, outsourcing components of data processing, cloud-scale genomics workflows, or managed services to support lean operations.

Cloud & Tech Stack Alignment Usage of cloud and web technologies such as AWS and OpenResty/Nginx suggests receptivity to scalable, compliant cloud-based genotyping, data analytics, and secure data exchange solutions; propose integrated platforms for data processing, storage, and collaboration.

54gene Tech Stack

54gene uses 8 technology products and services including LiteSpeed Cache, Amazon Web Services, Open Graph, and more. Explore 54gene's tech stack below.

  • LiteSpeed Cache
    Caching
  • Amazon Web Services
    Cloud Hosting
  • Open Graph
    Content Management System
  • Microsoft Excel
    Editors
  • AOS
    Javascript Libraries
  • OpenResty
    Web Servers
  • Nginx
    Web Servers
  • Google Plus
    Widgets

Media & News

54gene's Email Address Formats

54gene uses at least 1 format(s):
54gene Email FormatsExamplePercentage
First.Last@54gene.comJohn.Doe@54gene.com
78%
Last@54gene.comDoe@54gene.com
10%
First@54gene.comJohn@54gene.com
8%
Last.First@54gene.comDoe.John@54gene.com
4%

Frequently Asked Questions

What is 54gene's official website and social media links?

Minus sign iconPlus sign icon
54gene's official website is 54gene.com and has social profiles on LinkedInCrunchbase.

What is 54gene's SIC code NAICS code?

Minus sign iconPlus sign icon
54gene's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 54gene have currently?

Minus sign iconPlus sign icon
As of July 2026, 54gene has approximately 115 employees across 5 continents, including AfricaNorth AmericaEurope. Key team members include Associate Director Of Projects And Operations: N. I.Senior Operations Manager Fwa: A. S.Operations Manager: E. O.. Explore 54gene's employee directory with LeadIQ.

What industry does 54gene belong to?

Minus sign iconPlus sign icon
54gene operates in the Biotechnology Research industry.

What technology does 54gene use?

Minus sign iconPlus sign icon
54gene's tech stack includes LiteSpeed CacheAmazon Web ServicesOpen GraphMicrosoft ExcelAOSOpenRestyNginxGoogle Plus.

What is 54gene's email format?

Minus sign iconPlus sign icon
54gene's email format typically follows the pattern of First.Last@54gene.com. Find more 54gene email formats with LeadIQ.

How much funding has 54gene raised to date?

Minus sign iconPlus sign icon
As of July 2026, 54gene has raised $95M in funding. The last funding round occurred on Oct 28, 2022 for $50M.

When was 54gene founded?

Minus sign iconPlus sign icon
54gene was founded in 2019.
54gene logo

54gene

Biotechnology ResearchLagos, Nigeria51-200 Employees

54gene is a biotechnology research company headquartered in Lagos, Nigeria, with 51-200 employees. It focuses on genomics research, services, and development, and highlights the underrepresentation of African genetic data in global pharmaceutical research, noting that most genetic material used in drug development is of Caucasian origin. In 2022, 54gene completed a Series B funding round with investors including Cathay AfricInvest Innovation Fund and Adjuvant Capital. In March 2023, Ron Chiarello was appointed chief executive officer. More information is available on its website at https://54gene.com.

Section iconCompany Overview

Website
54gene.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $95M

    54gene has raised a total of $95M of funding over 10 rounds. Their latest funding round was raised on Oct 28, 2022 in the amount of $50Mas a convertible_note.

  • $1M$10M

    54gene's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $95M

    54gene has raised a total of $95M of funding over 10 rounds. Their latest funding round was raised on Oct 28, 2022 in the amount of $50Mas a convertible_note.

  • $1M$10M

    54gene's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.